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Background: The aim of this trial was to compare the effects of resistance training versus passive physical therapy
on quality of life (QoL), fatigue, and emotional distress outcomes during radiation therapy in patients with spinal
bone metastases under radiotherapy (RT).
Methods: In this randomized trial, 60 patients were treated from September 2011 until March 2013 into one of the
two groups: isometric resistance training or physical therapy with thirty patients in each group during RT. EORTC
QLQ-BM22, EORTC QLQ-FA13, and FBK-R10 were assessed at baseline, three months, and six months after RT.
Results: Psychosocial aspects in resistance training group (Arm A) were significantly improved after three (p = 0.001)
and six months (p = 0.010). Other rated items of the QLQ-BM22 painful site, and pain characteristics were without
significant differences. Functional interference showed a positive trend after six months (p = 0.081). After six months,
physical fatigue (p = 0.013), and interference with daily life (p = 0.006) according to the QLQ-FA13 assessment improved
in Arm A significantly. Emotional distress was in Arm A lower after six months (p = 0.016). The Cohen’s effect size
confirmed the clinically significant improvement of these findings.
Conclusions: In this group of patients we were able to show that guided isometric resistance training of the
paravertebral muscles can improve functional capacity, reduce fatigue and thereby enhance QoL over a 6-months
period in patients with stable spinal metastases. The results offer a rationale for future large controlled investigations to
confirm these findings.
Trial registration: Clinical trial identifier NCT01409720Background
Spinal bone metastases of an advanced stage of a malig-
nant primary disease are frequently associated with a de-
cline of quality of life (QoL) and fatigue. Approximately
70% of cancer patients report experiences of fatigue dur-
ing chemo- or radiotherapy [1]. The effects of bone me-
tastases result in resting pain and during physical stress,
limitation in daily life, lower performance ability, risk of
pathological fractures and neurological deficits. Pain is* Correspondence: harald.rief@med.uni-heidelberg.de
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unless otherwise stated.the most significant factor for reduced QoL of patients
with bone metastases. Fatigue is one of the most preva-
lent and distressing symptoms reported by cancer pa-
tients [2] and is described as an unusual feeling of
exhaustion, tiredness, feebleness, and reduced perform-
ance ability [3]. Cancer-related fatigue is a serious prob-
lem that impairs patients physically, mentally, and
socially [4,5] and previous trials have identified these
symptoms in patients with an advanced stage of a malig-
nant primary disease.
Although there has been frequent research throughout
recent decades, physical exercise for cancer patients is a
potential and effective intervention to treat fatigue and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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spinal bone metastases was considered inappropriate
due to the risk of pathological fractures and spinal cord
compression [13]. Accordingly the effect of resistance
training during RT of patients with spinal bone metasta-
ses is still unknown. The aim of this randomized trial
was to compare the effects of resistance training versus
passive physical therapy on quality of life, fatigue, and
emotional distress outcomes during radiation therapy in
patients with spinal bone metastases.
Methods
Subjects and recruitment
From September 2011 through March 2013, consecutive
80 patients with a histologically confirmed cancer of any
primary and bone metastases of the thoracic or lumbar
segments of the vertebral column, or of the os sacrum
were considered in the Radiooncology Department of the
Heidelberg University Clinic. Inclusion criteria were an
age of 18 to 80 years, a Karnofsky performance score
[14] ≥ 70, written consent to participate, and already initi-
ated bisphosphonate therapy. The patients were subjected
to a staging of their vertebral column within the context
of the CT designed to plan the radiation schedule prior to
enrolment into the trial. In this examination metastases in
the thoracic and lumbar spine were classified as “stable”80 patients s
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Figure 1 Flow of participants through the trial.or “unstable”. This was diagnosed independently by a spe-
cialist for radiology as well as by a specialist for orthopedic
surgery. The specifications for an unstable vertebral body
were tumor occupancy more than 60% of the vertebral
body, and pedicle destruction [15]. Only a metastasis clas-
sified by both specialists as “stable” was suggested eligible
for inclusion. Out of 80 patients considered eligible 15 pa-
tients were excluded due to unstable metastases, and five
patients declined to participate in the study. The initial
sample size 60 patients fulfilled the inclusion and were en-
rolled into the trial (Figure 1). The study was approved by
the Heidelberg Ethics Committee (Nr. S-316/2011).
Design, randomized allocation, and procedures
This is a randomized, controlled, explorative interven-
tion trial in the parallel group design with the intention
to compare the effects of quality-of-life and fatigue of a
resistance training program for strengthening the para-
vertebral muscles in patients with spinal bone metasta-
ses as an adjunct to radiotherapy (RT). Patients in the
control group conducted physical therapy in the form of
breathing exercises. A block randomization approach
was used. After the baseline measurements, the patients
with stable bone metastases were assigned to the re-
spective treatment arms on a 1:1 basis according to the
randomization list. The randomization procedure wascreened
15 unstable metastases
5 patients rejected trial
rolled with 
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22 completed 12 week 
follow-up in control group
18 completed 24 week 
follow-up in control group
Table 1 Patient characteristics at baseline
Intervention
group (n = 30)
Control group
(n = 30)
n % n %
Age (years)
Mean (SD) 61.3 (10.1) 64.1 (10.9)
Gender
Male 14 46.7 19 63.3
Female 16 53.3 11 36.7
Body Mass Index
Mean (SD) 25.3 (4.5) 24.4 (3.6)
Karnofsky PS (median, range) 80 (70-100) 80 (70-100)
Primary site
Lung 12 9.2 8 26.6
Breast 5 16.7 6 20.1
Prostate 5 16.7 9 30.1
Melanoma 1 3.3 1 3.3
Kidney 1 3.3 2 6.7
Other 6 20.1 4 13.4
Spinal metastases site
Thoracic 17 56.7 14 46.7
Lumbar 9 30.0 13 43.3
Thoracic and lumbar 2 6.7 2 6.7
Sacrum 2 6.7 1 3.3
Number of metastases
Mean (range) 1.4 (2-4) 1.7 (1-5)
Solitary 22 73.3 18 60.0
Multiple 8 26.7 12 40.0
Type of metastases
Mixed 2 6.7 2 6.7
Osteoblast 9 30.0 10 33.3
Osteolytic 19 63.3 18 60.0
Concomitant metastases at baseline
Visceral 12 40.0 5 16.7
Brain 3 10.0 3 10.0
Lung 7 23.3 4 13.3
Tissue 8 26.7 6 20.0
Hormonotherapy 10 33.3 16 53.3
Immunotherapy 7 23.3 5 16.7
Chemotherapy 25 83.3 20 66.7
Pathological fracture at baseline 6 20.0 9 30.0
Neurological deficit 0 0.0 2 6.7
SD Standard deviation.
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group, resistance training) and in Arm B (control group,
physical therapy) each consisted of 30 patients. The tar-
get parameters were measured at the start of radiother-
apy (t0), after twelve weeks (t2), and after six month (t3).
The target parameters comprise the documentation and
completion of the questionnaires EORTC QLQ-BM22,
EORTC QLQ-FA13, QSC-R10, and the recording of
patient-specific data. The data of the patient records
were collected by the authors. Patient characteristics are
shown in Table 1.
Study interventions
The interventions commenced on the same day as radio-
therapy and were performed on each day of RT treat-
ment (Monday through Friday) over a two-week period,
independent of the number of fractions. During the two-
week RT period, the patients in the resistance training
group (Arm A) performed the exercises under the guid-
ance of a physiotherapist. The patients were then
instructed to practice the training in their homes three
times a week and continued the resistance training
themselves until the last investigation after six months.
The resistance training lasted approx. 30 min, the phys-
ical therapy (Arm B) approx. 15 min. Since the site of
the bone metastases differed from patient to patient,
three different exercises were enacted to ensure an even
isometric resistance training of the muscles along the
entire vertebral column. Patients in the control group
(Arm B) received passive physical therapy in form of
breathing exercises also for a period of two weeks. The
passive physical therapy was conducted for patients’
compliance, and avoidance of a high drop out rate. A de-
tailed report of the intervention and its application has
already been published [16].
Measures of primary and secondary End points
The primary endpoint was QoL, assessed using the
EORTC QLQ BM22 questionnaire, which is specially de-
signed for patients with bone metastases. The QLQ
BM22 module (range 0-100) comprises 22 items and
four scales for the measurement of pain in various parts
of the body (painful sites), pain characteristics (persistent
pain, recurrent pain), functional impairment (occurrence
of pain when performing different activities, interference
with everyday activities), and psychosocial aspects (fam-
ily, worries, hope) [17]. Secondary endpoints were fa-
tigue, and emotional distress. Fatigue was assessed using
the EORTC QLQ FA13 (range 0-100). This QLQ FA13
module includes 13 items and five scales for measuring
cancer-related fatigue [18], with subscales covering phys-
ical fatigue, emotional fatigue, cognitive fatigue, interfer-
ence with daily life, and social sequelae. Emotional
distress was assessed using the QSC-R10 (range 0-50)questionnaire. The QSC-R10 [19] module is a valid and
reliable questionnaire for determining emotional distress
and anxiety in cancer patients [20]. The questionnaires
were filled out by the patients at the study site.
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Radiotherapy was performed in the Radiooncology De-
partment of the Heidelberg University Clinic. After vir-
tual simulation was performed to plan the radiation
schedule, radiotherapy was carried out over a dorsal
photon field of the 6MV energy range. PTV covered the
specific vertebral body affected as well as the ones im-
mediately above and below. In Arm A 24 patients (80%)
were treated with 10 × 3 Gy, three patients (10%) with
14 × 2.5 Gy, and three patients (10%) with 20 × 2 Gy. In
Arm B the dose fractions for 28 patients (93.3%) were
10 × 3 Gy, for one patient (3.3%) 14 × 2.5 Gy, and for
one patient (3.3%) 20 × 2 Gy. The median individual
dose in all patients was 3 Gy (range 2-3 Gy), the median
total dose 30 Gy (range 20-35 Gy). The individual and
total doses were decided separately for each individual
patient, depending on the histology, the patient’s general
state of health, and on the current staging and the corre-
sponding prognosis.
Sample calculation and statistical analysis
The total number of patients undergoing radiotherapy in
the radiation oncology department of the Heidelberg
University Clinic for metastatic processes in the verte-
bral column in the recruitment period is approx. 120,
about 90 of whom shall fulfill the inclusion criteria. On
account of the explorative character of this study it was
not possible to estimate the total number of cases; with
a scheduled number of 30 patients per group, it will,
however, be possible to detect a standardized effect
(Cohen’s d) of about 0.8 with a power of 80% and a sig-
nificance level α of 5%. All variables were analyzed de-
scriptively by tabulation of the measures of the empirical
distributions. According to the scale level of the vari-
ables, means, standard deviations, medians as well as
minimum and maximum or absolute and relative fre-
quencies, respectively, will be reported. Additionally, for
variables with longitudinal measurements, the time
courses of individual patients and summarized by treat-
ment groups. Descriptive p-values of the corresponding
statistical tests comparing the treatment groups will be
given. Wilcoxon signed rank test was used to compare
changes in group difference. The Cohen’s effect (ES) size
was assessed for clinically relevant change in question-
naires measures (<0.3 low, 0.3-0.7 moderate, >0.7 strong
difference).
Results
The mean follow-up was 6.3 month for both groups.
During the trial there were no adverse events. All surviv-
ing patients completed all surveys. Five patients (16.7%)
in Arm A died within the first twelve weeks following
RT, additional 7 patients (23.3%) died within 6 month
due to tumor progression. In Arm B died 8 patients(26.7%) within 3 month and further 4 patients (13.3%)
within 6 month. Mortality did not differ between groups.
Patients in the intervention group (Arm A) showed in
psychosocial aspects a statistical significant advantage
after three (p = 0.001) and six months (p = 0.010) (Table 2).
The Cohen’s effect size confirmed the clinically significant
improvement of the psychosocial aspects (ES -0.79).
The single item-analysis of psychosocial aspects
showed in Arm A, worries regarding the loss of mobility
were significantly lower after as early as three months
(p = 0.007), and sustained after six months (p = 0.048),
and were optimistic about their health. The control
group, on the other hand, reported considerably more
worries of becoming dependent on others (p = 0.015)
(Table 3). Other scales of the EORTC QLQ-BM22 like
painful site, and pain characteristics showed small to
moderate ES without however becoming significant be-
tween groups in favoring to the intervention group. The
functional interference showed a positive trend after six
months (p = 0.081, ES -0.56).
After six months, patients in Arm A had significant
lower physical fatigue (p = 0.013), and interference with
daily life (p = 0.006) according to the FA13 assessment.
Emotional and cognitive fatigue did not differ between
groups, neither after 3 nor 6 months (Table 4). Finally,
emotional distress was in the intervention group lower
after six months (p = 0.016) (Table 5) compared to con-
trol group. The effect size confirmed these findings.
Discussion
Bone metastases frequently occur in advanced cancer
diseases, and in the majority of cases are localized in the
spinal column. The sequelae include pain, a raised risk
of fracture, functional impairments and fatigue, all of
them contributing to deteriorated in quality of life. After
bone metastasis has been diagnosed, in many cases sev-
eral weeks or even months pass with a considerable re-
duction in quality of life and persistent symptoms of
pain. We therefore attempted to enhance patients’ QoL
by combining resistance training to radiotherapy. To our
knowledge, this randomized study is the first to investi-
gate the benefit of isometric exercises to strengthen the
paravertebral muscles of patients with spinal metastases
on pain sensation, functional capacity, QoL and fatigue.
Our results showed that patients report during and fol-
lowing radiotherapy a benefit from this adjunctive ther-
apy compared to control group undergoing radiotherapy
only, with regard to several domains of QoL and fatigue.
Substantial improvement with small to moderate effect
sizes could be observed in all dimensions of the EORTC
QLQ-BM 22 (painful sites, pain characteristics, func-
tional interference, and psychosocial aspects) compared
to control group both after three and six months. How-
ever, with the exception of psychosocial aspects (in the
Table 2 Effects of resistance training on Quality of life (EORTC QLQ-BM 22)
Symptom scales
Painful sites Intervention group (Arm A) Control group (Arm B)
n Mean SD n Mean SD
Baseline (t0) 30 39.78 23.91 30 39.56 24.51
3 month (t2) 25 29.6 19.73 22 35.76 27.1
6 month (t3) 18 22.22 13.14 18 35.93 32.67
Treatment effect (t0-t2) after 3 month p = 0.399, (t0-t3) after 6 month p = 0.445
Effect size (t0-t2) after 3 month -0.24, (t0-t3) after 6 month -0.43
Pain characteristics Intervention group (Arm A) Control group (Arm B)
n Mean SD n Mean SD
Baseline (t0) 30 48.15 31.47 30 54.81 33.13
3 month (t2) 25 25.78 17.78 22 41.92 35.62
6 month (t3) 18 25.31 19.73 18 45.06 36.65
Treatment effect (t0-t2) after 3 month p = 0.905, (t0-t3) after 6 month p = 0.761
Effect size (t0-t2) after 3 month -0.09, (t0-t3) after 6 month -0.24
Functional interference Intervention group (Arm A) Control group (Arm B)
n Mean SD n Mean SD
Baseline (t0) 30 55.14 26.32 30 55.28 28.95
3 month (t2) 25 35.33 20.35 22 44.7 30.38
6 month (t3) 18 29.86 20.77 18 48.38 30.12
Treatment effect (t0-t2) after 3 month p = 0.285, (t0-t3) after 6 month p = 0.081
Effect size (t0-t2) after 3 month -0.21, (t0-t3) after 6 month -0.56
Psychosocial aspects Intervention group (Arm A) Control group (Arm B)
n Mean SD n Mean SD
Baseline (t0) 30 69.26 17.0 30 57.59 19.87
3 month (t2) 25 45.56 19.71 23 54.55 20.9
6 month (t3) 18 41.05 19.1 18 50.93 20.55
Treatment effect (t0-t2) after 3 month p = 0.001, (t0-t3) after 6 month p = 0.010
Effect size (t0-t2) after 3 month -0.79, (t0-t3) after 6 month -0.77
Treatment effect and Cohen’s effect size after 3 and 6 month.
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tween groups did not reach statistical significance; which
is predominantly due to the small sample size. The psy-
chosocial item was elicited in each individual question
to identify at which points the difference was particularly
apparent. In particular, patients in the intervention
group reported worrying less about a potential loss of
mobility as early as three months. After six months, the
difference in worries became significant between groups.
Patients who were regularly exercising also reported a
more favourable state of health. By contrast, patients in
the control group worried to a considerably greater ex-
tent on becoming dependent on others.
Some recent studies have provided indications of a
large, clinically relevant short-term effect produced by
exercise therapy [21]. Segal et al. reported that QoL
assessed in FACT-General Scale was improved in a ran-
domized study involving exercise training in patientswith prostate cancer [22]. Ohira et al. showed a signifi-
cant improvement in exercise training compared with a
control group in the CARES-SF subscale for physical
QoL and psychosocial QoL [23], indicating that exercise
training is capable of exerting a positive effect on muscle
growth and consequently on mobility in breast cancer
survivors. In our study, patients in the intervention
group were experiencing less pain-related “functional
interference” and showed a positive trend after six months
(p = 0.081).
As patients are experiencing increased performance
status, this probably enhances the sense of control, in-
dependence, and self-esteem, which in turn leads to
better social interactions and decreased anxiety and
fear. To determine the clinical relevance by calculating
Cohen’s effect size, a clinically significant improvement
of the “psychosocial aspects’ scale” (ES -0.79) could be
confirmed.
Table 3 Item analysis of “psychosocial aspects” scale
Intervention group (Arm A) Control group (Arm B) Treatment effect
Baseline 3 month 6 month Baseline 3 month 6 month 3 month 6 month
Item Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD p-value p-value
17 1.5 0.8 1.2 0.5 1.3 0.6 1.3 0.6 1.4 0.7 1.4 0.7 0.117 0.560
18 3.4 0.9 2.6 1.1 2.1 1.1 2.7 1.0 2.9 1.2 2.6 1.1 0.007 0.015
19 3.2 1.1 2.4 1.2 2.2 1.0 2.6 1.1 2.5 1.3 2.4 1.2 0.015 0.029
20 3.5 0.9 2.6 1.1 2.4 1.0 3.4 1.0 3.1 0.9 2.9 0.9 0.116 0.314
21 3.6 0.6 2.7 1.2 2.6 1.1 3.4 0.9 3.0 1.1 2.9 1.2 0.118 0.233
22 3.2 0.7 2.6 1.1 2.8 1.0 3.0 0.9 2.8 0.9 3.0 0.9 0.101 0.048
Questions
17 Have you felt isolated from those close to you?
18 Have you worried about loss of mobility because of your illness?
19 Have you worried about becoming dependent on others because of your illness?
20 Have you worried about your health in the future?
21 Have you felt hopeful your pain will get better?
22 Have you felt positive about your health?
Results of the subscale (questions 17-22) according to EORTC QLQ-BM22.
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ive sensation of tiredness relating to cancer treatment that
impairs the patients’ physical and mental performance
[24], and is the symptom of greatest clinical relevance for
patients in an advanced stage of cancer disease [25]. Accu-
mulating evidence from intervention studies indicates that
exercise programmes are effective both in reducing the in-
tensity of cancer-related fatigue and also help to prevent
fatigue from becoming manifest [26-28].
In line with other authors’ findings, in our study resist-
ance training was shown to result in substantial reduc-
tion of physical fatigue and interference with daily after
6 months whereas no changes in emotional and cogni-
tive fatigue were observed.
Dimeo et al. [26] have already demonstrated that an
exercise programme of limited duration not only im-
proves the functional status and stamina, but also results
in a major reduction in fatigue in cancer patients. Exer-
cise therapy is a highly promising and effective thera-
peutic approach in sustainably combating cancer-related
fatigue [20,22,29]. As demonstrated in this study, a
simple-to-perform regimen of isometric exercises can be
of substantial benefit, even to advanced-stage cancer pa-
tients. Our results showed a statistically significant bene-
fit for the intervention group in all fatigue items, in
particular regarding physical fatigue and interference
with daily life. The intervention resulted in an improve-
ment of mobility in daily life, which might have had an
impact on reduced fatigue.
Moderate fatigue was shown in 66% of advanced stage
cancer patients prior to radiotherapy [30]. This high
prevalence of fatigue further underscores the importanceof exercise therapy combined with palliative radiother-
apy, respectively. Psychosocial distress, depression and
anxiety are particularly prevalent in advanced disease
stages, with proportions of clinical depression and anx-
iety patients ranging from 20 to 39% [31]. Our results
showed a significant improvement in emotional distress
and anxiety at 6-months follow-up, however, the effect
size suggested a strong clinical effect. The effects of re-
sistance training became apparent and significant in re-
duced sample after six months, what suggests only a
benefit for survivors longer than six months. For plan-
ning further clinical trials in this setting, we recommend
a Karnofsky performance score [14] < 70, and unstable
metastases as exclusion criteria.
Because all patients were in advanced stages of their
cancer, 40% of the patients in either group were lost to
follow-up due to progressive disease and subsequently
death. Further limitations of the study were the relatively
small sample size, the variety of primary tumors and pa-
tient conditions, and the exclusion of patients presenting
with cervical spine metastases. For feasibility reasons,
patients’ compliance with the training program in their
homes was assessed only by relying on patient-completed
documentation forms.
Among the strengths of the study were the random-
ized design and a relatively low drop-out rate, as well as
standardized and specific measures to assess multiple
domains of QoL among patients with bone metastases.
This is, to our knowledge, the very first application of a
resistance exercise program in patients with spinal me-
tastases concomitant to radiotherapy, to enhance their
functional capacity and mobility, to reduce their fatigue
Table 4 Effects of resistance training on fatigue (EORTC QLQ-FA 13)
Physical fatigue Intervention group (Arm A) Control group (Arm B)
n Mean SD n Mean SD
Baseline (t0) 30 57.22 29.0 30 58.06 29.1
After 3 month (t2) 25 49.0 24.92 22 56.44 30.53
After 6 month (t3) 18 35.65 25.37 18 64.91 31.25
Treatment effect (t0-t2) after 3 month p = 0.637, (t0-t3) after 6 month p = 0.013
Effect size (t0-t2) after 3 month -0.04, (t0-t3) after 6 month -0.71
Emotional fatigue Intervention group (Arm A) Control group (Arm B)
n Mean SD n Mean SD
Baseline (t0) 30 46.67 32.5 30 44.44 30.27
After 3 month (t2) 25 33.67 25.63 22 43.18 34.85
After 6 month (t3) 18 27.31 27.54 18 46.05 33.26
Treatment effect (t0-t2) after 3 month p = 0.796, (t0-t3) after 6 month p = 0.156
Effect size (t0-t2) after 3 month -0.14, (t0-t3) after 6 month -0.35
Cognitive fatigue Intervention group (Arm A) Control group (Arm B)
n Mean SD n Mean SD
Baseline (t0) 30 21.11 21.71 30 17.78 22.15
After 3 month (t2) 25 16.89 23.16 22 22.22 25.89
After 6 month (t3) 18 19.14 20.45 18 19.30 21.23
Treatment effect (t0-t2) after 3 month p = 0.248, (t0-t3) after 6 month p = 0.433
Effect size (t0-t2) after 3 month -0.24, (t0-t3) after 6 month -0.19
Interference with daily life Intervention group (Arm A) Control group (Arm B)
n Mean SD n Mean SD
Baseline (t0) 30 2.53 0.94 30 2.30 1.09
After 3 month (t2) 25 2.20 1.04 22 2.64 1.00
After 6 month (t3) 18 1.89 0.96 18 3.05 0.97
Treatment effect (t0-t2) after 3 month p = 0.093, (t0-t3) after 6 month p = 0.006
Effect size (t0-t2) after 3 month -0.48, (t0-t3) after 6 month -0.91
Social sequelae Intervention group (Arm A) Control group (Arm B)
n Mean SD n Mean SD
Baseline (t0) 30 1150 0.78 30 1.43 0.86
After 3 month (t2) 25 1.24 0.52 22 1.64 1.00
After 6 month (t3) 18 1.22 0.43 18 1.79 1.23
Treatment effect (t0-t2) after 3 month p = 0.129, (t0-t3) after 6 month p = 0.363
Effect size (t0-t2) after 3 month -0.40, (t0-t3) after 6 month -0.37
Table 5 Effects of emotional distress according to FBK-R10
questionnaire
FBK-R10 Intervention group (n = 30) Control group (n = 30)
n Mean SD n Mean SD
Baseline (t0) 30 24.7 10.8 30 24.13 12.1
3 month (t2) 25 18.84 9.2 22 22.41 11.8
6 month (t3) 18 15.44 8.6 18 24.95 12.8
Treatment effect (t0-t2) after 3 month p= 0.106, (t0-t3) after 6 month p= 0.016.
Effect size (t0-t2) after 3 month -0.34, (t0-t3) after 6 month -0.87.
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improve their QoL.
Conclusion
In this group of patients we were able to show that
guided isometric resistance training of the paravertebral
muscles can improve functional capacity, reduce fatigue
and thereby enhance QoL over a 6-months period in pa-
tients with stable spinal metastases. Importantly, the
intervention was able to reduce specific fears around
loss of mobility and depending on others‘assistance. This
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proach to reduce emotional distress and anxiety specific
to patients suffering from spinal metastases. Large con-
trolled trials are necessary to confirm these findings.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HR and JD developed and planned this trial. TB is responsible for statistical
considerations/basis of the analysis. GO, MA, and TW estimated the stability
of bone metastases. HR, MK, SR, MH, and IS performed the examinations and
RT supervisions. HR and AG made the data collection. HR performed the
physical exercise. All authors read and approved the final manuscript.
Acknowledgements
The authors thank all of the study participants for their great effort. We
would also like to thank our staff of the trial research office, especially
Alexandros Gioules.
Author details
1Department of Radiation Oncology, University Hospital of Heidelberg,
Im Neuenheimer Feld 400, Heidelberg 69120, Germany. 2Department of
Medical Biometry, University Hospital of Heidelberg, Im Neuenheimer
Feld 305, Heidelberg 69120, Germany. 3Department of Orthopaedics and
Trauma Surgery, University Hospital of Heidelberg, Schlierbacherstrasse
120a, Heidelberg 69118, Germany. 4Department of Psychooncology,
University Hospital of Heidelberg, Im Neuenheimer Feld 400, Heidelberg
69120, Germany.
Received: 10 March 2014 Accepted: 30 June 2014
Published: 7 July 2014
References
1. Smets EM, Garssen B, Schuster-Uitterhoeve AL, de Haes JC: Fatigue in cancer
patients. Br J Cancer 1993, 68:220–224.
2. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V: Assessment and
management of cancer-related fatigue in adults. Lancet 2003, 362:640–650.
3. Weis J: Cancer related fatigue: prevalence, assessment and treatment
strategies. Expert Rev Pharmacoecon Outcomes Res 2011, 11:441–446.
4. Richardson A: Measuring fatigue in patients with cancer. Support Care
Cancer 1998, 6(2):94–100.
5. Horneber M, Fischer I, Dimeo F, Rüffer JU, Weis J: Cancer-related fatigue:
epidemiology, pathogenesis, diagnosis, and treatment. Dtsch Arztebl Int
2012, 9:161–172.
6. Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G: Physical
exercise in cancer patients during and after medical treatment: a
systemic review of randomized and controlled trials. J Clin Oncol 2005,
23:3830–3841.
7. Cramp F, James A, Lampert J: The effects of resistance training on quality
of life in cancer: a systematic literature review and meta-analysis. Support
Care Cancer 2010, 18:1367–1376.
8. Mock V, Pickett M, Ropka ME, Muscari E, Stewart KJ, Rhodes VA, McDaniel R,
Grimm PM, Krumm S, McCorkle R: Fatigue and quality of life outcomes of
exercise during cancer treatment. Cancer Pract 2001, 9(3):119–127.
9. Maddocks M, Mockett S, Wilcock A: Is exercise an acceptable and practical
therapy for people with or cured of cancer? A systemic review. Cancer
Treat Rev 2009, 35(4):383–390.
10. Monga U, Garber SL, Thornby J, Vallbona C, Kerrigan AJ, Monga TN,
Zimmermann KP: Exercise prevents fatigue and improves quality of life in
prostate cancer patients undergoing radiotherapy. Arch Phys Med Rehabil
2007, 88:1416–1422.
11. Cheville AL, Girardi J, Clark MM, Rummans TA, Pittelkow T, Brown P, Hanson
J, Atherton P, Johnson ME, Sloan JA, Gamble G: Therapeutic exercise
during outpatient radiation therapy for advanced cancer. Am J Phys Med
Rehabil 2010, 89:611–619.
12. Nikander R, Sievänen H, Ojala K, Oivanen T, Kellokumpu-Lehtinen PL, Saarto
T: Effect of a vigorous aerobic regimen on physical performance in
breast cancer patients –a randomized controlled pilot trial. Acta Oncol
2007, 46:181–186.13. German Cancer Association: Guidelines for sports medicine and
prevention, supportive medicine and rehabilitation neoplastic disease
part II. Forum 2011, 5:9–12.
14. Karnofsky DA, Burchenal JH: The Clinical Evaluation of Chemotherapeutic
Agents in Cancer. In Evaluation of Chemotherapeutic Agents. Edited by
MacLeod CM. New York: 1949:191–205.
15. Taneichi H, Kaneda K, Takeda N, Abumi K, Satoh S: Risk factors and
probability of vertebral body collapse in metastases of the thoracic and
lumbar spine. Spine 1997, 22:239–245.
16. Rief H, Jensen AD, Bruckner T, Herfarth K, Debus J: Isometric muscle
training of the spine musculature in patients with spinal bony
metastases under radiation therapy. BMC Cancer 2011, 11:482.
17. Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V,
Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bottomley A:
International field testing of the reliability and validity of the EORTC
QLQ-BM22 Module to assess health-related quality of life in patients
with bone metastases. Cancer 2012, 3:1457–1465.
18. Weis J, Arraras JI, Conroy T, Efficace F, Fleissner C, Görög A, Hammerlid E,
Holzner B, Jones L, Lanceley A, Singer S, Wirtz M, Flechtner H, Bottomley A:
Development of an EORTC quality of life phase III module measuring
cancer-related fatigue (EORTC QLQ-FA13). Psychooncology 2013,
22(5):1002–1007.
19. Book K, Marten-Mittag B, Henrich G, Dinkel A, Scheddel P, Sehlen S, Haimerl
W, Schulte T, Britzelmeir I, Herschbach P: Distress screening in oncology-
evaluation fo the Questionaire on distress in cancer patients-short form
(QSC-R10) in a german sample. Psychooncology 2011, 20:287–293.
20. Escalante CP: Treatment of cancer-related fatigue: an update. Support
Care Cancer 2003, 11:79–83.
21. Daley AJ, Crank H, Saxton JM, Mutrie N, Coleman R, Roalfe A: Randomized
trial of exercise therapy in women treated for breast cancer. J Clin Oncol
2007, 25:1713–1721.
22. Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Sigal RJ, Kenny GP,
Prud’Homme DG, Malone SC, Wells GA, Scott CG, Slovinec D’Angelo ME:
Randomized controlled trial of resistance or aerobic exercise in men
receiving radiation therapy for prostate cancer. J Clin Oncol 2008, 27:344–351.
23. Ohira T, Schmitz KH, Ahmed RL, Yee D: Effects of weight training on quality
of life in recent breast cancer survivors. Cancer 2006, 106:2076–2083.
24. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, Cella D,
Cimprich B, Cleeland C, Donnelly J, Eisenberger MA, Escalante C, Hinds P,
Jacobsen PB, Kaldor P, Knight SJ, Peterman A, Piper BF, Rugo H, Sabbatini P,
Stahl C: MCCM practice guidelines for cancer-related fatigue. Oncology
2000, 14:151–161.
25. Mock V, Dow KH, Meares C, Grimm PM, Dienemann JA, Haisfield-Wolfe ME,
Quitasol W, Mitchell S, Chakravarthy A, Gage I: Effects of exercise on
fatigue, physical functioning and emotional distress during radiation
therapy for breast cancer. Oncol Nurs Forum 1997, 24:991–1000.
26. Dimeo FC, Fetscher S, Lange W, Mertelsmann R, Keul J: Effects of aerobic
exercise on the physical performance and incidence of treatment-related
complications after high-dose chemotherapy. Blood 1997, 90:3390–3394.
27. Dimeo FC: Effects of exercise on cancer-related fatigue. Cancer 2001,
92:1689–1693.
28. Cramp F, Daniel J: Exerc8ise for the management of cancer-related
fatigue in adults. Cochrane Database Syst Rev 2012, 14:11.
29. Dimeo F, Schwartz S, Wesel N, Voigt A, Thiel E: Effects of an endurance
and resistance exercise program on persistent cancer-related fatigue
after treatment. Ann Oncol 2008, 19:1495–1499.
30. Zeng L, Koo K, Zhang L, Jon F, Jon F, Dennis K, Holden L, Nguyen J, Tsao M,
Barnes E, Danjoux C, Sahgal A, Chow E: Fatigue in advanced cancer
patients attending an outpatient palliative radiotherapy clinic as
screened by the Edmonton symptom assessment system. Support Care
Cancer 2012, 20(5):1037–1042.
31. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N:
Prevalence of depression, anxiety, and adjustment disorder in
oncological, haematological, and palliative-care settings: a meta-analysis
of 94 interview-based studies. Lancet Oncol 2011, 12(2):160–174.
doi:10.1186/1748-717X-9-151
Cite this article as: Rief et al.: Quality of life and fatigue of patients with
spinal bone metastases under combined treatment with resistance
training and radiation therapy- a randomized pilot trial. Radiation
Oncology 2014 9:151.
